Discordant Erythrocyte Sedimentation Rate and C-reactive Protein in Children With Inflammatory Bowel Disease Taking Azathioprine or 6-Mercaptopurine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 38, Issue 5, 2004, Pages 509-512

  Barnes, Barrett H ^a   Borowitz, Stephen M ^a   Saulsbury, Frank T ^a   Hellems, Martha ^a   Sutphen, James L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE;

ADOLESCENT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHILD; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; EVALUATION; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; PREDICTION AND FORECASTING;

6-MERCAPTOPURINE; ADOLESCENT; AZATHIOPRINE; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALE; PREDICTIVE VALUE OF TESTS;

EID: 3543130088     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200405000-00009     Document Type: Article

References (21)

1. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
2. Barabino A, Torrente F, Ventura A, et al. Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey. Aliment Pharmacol Ther 2002;16:1125-30.
3. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998;115:813-21.
4. Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22.
5. Jaye DL, Waites KB. Clinical applications of c-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-47.
6. Hyams JS, Ferry BD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
7. Best WR, Beckel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
8. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;2:514.
9. Wright JP, Yojng GO, Tigler-Wybrandi N. Predictors of acute relapse of Crohn's disease-a laboratory and clinical study. Dig Dis Sci 1987;32:164-70.
10. Andre C, Descos L, Vignal J, et al. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease. Scott Med J 1983;28:26-9.
11. Boirivant V, Leoni M, Taricotti D, et al. The clinical significance of serum c-reactive protein levels in Crohn's disease. J Clin Gastroenterol 1988;10:401-5.
12. Kjeldsen J, Lauritsen K, De Muckadell OB. Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with inflammatory bowel disease. Scand J Gastroenterol 1997;32:933-41.
13. Brignola C, Iannone P, Belloli C, et al. Predication of relapse in patients with Crohn's disease in remission: a simplified index using laboratory tests, enhanced by clinical characteristics. Eur J Gastroenterol Hepatol 1994;6:955-61.
14. Brignola C, Campieri M, Bazzocchi G, et al. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterol 1986;91:1490-4.
15. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
16. Zlonis M. The mystique of the erythrocyte sedimentation rate. Clin Lab Med 1993;13:787-800.
17. Hilliard NJ, Waites KB. C-reactive protein and ESR: what can one test tell you that the other can't?Contemp Pediatr 2002;19:64-74.
18. Wolfe F. Comparative usefulness of c-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85.
19. Amos RS, Constable TJ, Crockson RA, et al. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1977;1:195-7.
20. Bernstein CN, Artinian L, Anton PA, et al. Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity. Dig Dis Sci 1994;39:1638-41.
21. Reinhart WH, Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995;25:523-8.